Eric Pauwels, Chief Business Officer, on June 10, 2026, sold 21,277 shares in PTC Therapeutics (PTCT) for $1,595,775. Following the Form 4 filing with the SEC, Pauwels has control over a total of 73,411 common shares of the company, with 73,411 shares held directly.
SEC Filing:
J Danforth Quayle, Director, on June 10, 2026, sold 14,525 shares in Carvana (CVNA) for $1,016,750. Following the Form 4 filing with the SEC, Quayle has control over a total of 277,460 Class A common shares of the company, with 214,960 shares held directly and 62,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1690820/000121041226000006/xslF345X05/wk-form4_1781213824.xml
Anthony Grillo, Director, on June 11, 2026, sold 3,000 shares in Littelfuse (LFUS) for $1,355,867. Following the Form 4 filing with the SEC, Grillo has control over a total of 64,928 common shares of the company, with 64,928 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/889331/000107084726000010/xslF345X05/wk-form4_1781213474.xml
D James Bidzos, Director, Executive Chairman, President, & CEO, on June 09, 2026, sold 3,300 shares in Verisign (VRSN) for $938,169. Following the Form 4 filing with the SEC, Bidzos has control over a total of 436,039 common shares of the company, with 436,039 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1014473/000120481626000014/xslF345X05/wk-form4_1781213570.xml